CNS drug discovery has one of the worst attrition rates in pharma. Spatial biology offers a way to understand brain disease in its native architecture.
A new AI analysis of a negative Alzheimer's trial raises questions about whether conventional clinical trials are missing patients who could still benefit from treatment.
Biomarker discovery has long thrown away the tissue’s spatial information. Recovering it is turning up signatures no dissociated assay could ever have found.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.